Stuart W. Peltz
2021
In 2021, Stuart W. Peltz earned a total compensation of $11M as Chief Executive Officer at PTC Therapeutics, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $835,300 |
|---|---|
| Option Awards | $7,550,900 |
| Salary | $768,750 |
| Stock Awards | $1,835,124 |
| Other | $32,249 |
| Total | $11,022,323 |
Peltz received $7.6M in option awards, accounting for 69% of the total pay in 2021.
Peltz also received $835.3K in non-equity incentive plan, $768.8K in salary, $1.8M in stock awards and $32.2K in other compensation.
Rankings
In 2021, Stuart W. Peltz's compensation ranked 885th out of 12,397 executives tracked by ExecPay. In other words, Peltz earned more than 92.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 885 out of 12,397 | 93rd |
Division Manufacturing | 289 out of 5,492 | 95th |
Major group Chemicals And Allied Products | 96 out of 2,367 | 96th |
Industry group Drugs | 81 out of 2,090 | 96th |
Industry Pharmaceutical Preparations | 52 out of 1,537 | 97th |
Source: SEC filing on April 28, 2022.
Peltz's colleagues
We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2021.